All 20 patients who received the CAR-T in the Phase II study were MRD negative at the data cutoff, but some also had lingering neurotoxicities.

The research on bone-marrow transplantation mirrors the arc of many medical advancements. I was one of the early ...

Just months ago, Broeden Sabin was riding dirt bikes and snowboarding. Now, he's awaiting a bone marrow donor to save his ...

Bone marrow transplants are increasingly being used to treat non-cancer conditions like thalassemia and sickle cell disease, ...